Sign Up

BLFE

COM:BIOLIFESCIENCES

BioLife Sciences

  • Stock

USD

Market Cap

118

Beta: -

Volume Today

50

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Feb '21
May '21
Aug '21
Feb '22
Aug '22
Nov '22
Feb '23
May '23
Aug '23
net income
-67.36K
-
-137.76K
104.51%
-143.16K
3.93%
-132.05
99.91%
depreciation and amortization
deferred income tax
stock based compensation
27.09
-
49.85
-
change in working capital
-5.64K
-
62.75K
1,212.54%
82.80K
31.96%
accounts receivables
inventory
-23.52
-
accounts payables
17.88K
-
63.07K
252.78%
82.88K
31.40%
other working capital
-23.52K
-
-326
98.61%
-80
75.46%
other non cash items
9.21K
-
-27.28K
396.24%
-33.23K
21.82%
80.24
100.24%
net cash provided by operating activities
-45.91K
-
-39.21K
14.59%
-10.71K
72.68%
-1.96
99.98%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
-75K
-
common stock issued
common stock repurchased
dividends paid
other financing activites
75
-
net cash used provided by financing activities
75K
-
effect of forex changes on cash
12.05
-
0.50
-
net change in cash
29.10K
-
-39.21K
234.76%
-10.71K
72.68%
-1.46
99.99%
cash at beginning of period
46.77K
-
79.51K
69.98%
40.29K
49.32%
17.08
99.96%
cash at end of period
75.88K
-
40.29K
46.90%
29.58K
26.59%
15.62
99.95%
operating cash flow
-45.91K
-
-39.21K
14.59%
-10.71K
72.68%
-1.96
99.98%
capital expenditure
free cash flow
-45.91K
-
-39.21K
14.59%
-10.71K
72.68%
-1.96
99.98%

All numbers in USD (except ratios and percentages)